PICO study
A study to test the effect of phenylalanine on brain functions
Due to a rare metabolic defect, patients suffering from phenylketonuria (PKU) cannot process the amino acid phenylalanine (Phe). A build-up of Phe in the body causes severe brain damage and developmental disorders in children. To avoid this build-up, a low-Phe (i.e. low-protein) diet must be followed in children with PKU. To what extent adult patients with PKU must follow such a strict diet remains unclear to this day. The PICO study investigates the influence of increased Phe levels on the adult brain of patients with PKU. For this purpose, a short-term break in the Phe-free diet is simulated by administering Phe capsules and changes in the brain are examined with the help of neuropsychological tests, structural and functional MRI.
Financial support
- Swiss National Science Foundation (SNSF)
- Vontobel-Foundation
- Bangerter-Rhyner Foundation
- Nutricia Metabolics Research Fund
- Research Grant Inselspital Bern
- Fondation Rolf Gaillard
- Foundation for the Promotion of Nutrition Research in Switzerland
- Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern
Collaborations
- Bern University Hospital and University of Bern: PD Dr. Johannes Slotboom, PD Dr. rer. nat. Christian Rummel, Prof. Dr. sc. nat. Roland Kreis, PD Dr. med. Yosuke Morishima
- Maastricht Brain Imaging Center, Maastricht University, Niederlande: Prof. Dr. Bernadette Jansma
- University of Zurich: Prof. Dr. Nicolas Langer
Study information
- Download brochure patients (german) [295.95 KB]
- Download Broschure Patientes/Patients (français) [293.03 KB]